This inventor holds 15 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: The J. David Gladstone Institutes, University of California, The J. David Gladstone Institutes, a Testamentary Trust Established Under the Will of J. David Gladstone. Active years: 2001-2024.
Location History:
- South San Francisco, CA (US) (2022)
- Hillsborough, CA (US) (2001 - 2023)
- San Francisco, CA (US) (2003 - 2024)
Company Filing History:
9 out of 91 
4 out of 16,008 
2 out of 22 Years Active: 2001-2024
Title: Warner C Greene: Innovator in Medical Research
Introduction
Warner C Greene is a prominent inventor based in Hillsborough, CA, known for his significant contributions to medical research. He holds a total of 15 patents, showcasing his innovative approach to addressing critical health issues.
Latest Patents
One of his latest patents is an animal model for SARS-CoV-2-spike induced coagulopathy. This model is designed to identify therapeutic agents that can mitigate the physiological effects of COVID-19 infection, including inflammation, oxidative stress, fibrin deposition, blood-brain barrier breakdown, clotting, and vascular problems. Another notable patent involves compositions and methods for reactivating latent immunodeficiency virus using a GSK-3 inhibitor. This patent outlines the use of glycogen synthase kinase 3 inhibitors, such as Tideglusib and SB-216763, to reactivate latent immunodeficiency virus.
Career Highlights
Warner C Greene has worked with esteemed institutions, including the J. David Gladstone Institutes and the University of California. His work has significantly advanced the understanding of viral infections and their treatment.
Collaborations
Throughout his career, Greene has collaborated with notable colleagues, including Michael P Sherman and Ulrich Schubert. These partnerships have further enriched his research and innovation efforts.
Conclusion
Warner C Greene's contributions to medical research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact the development of therapeutic solutions for critical health challenges.